{"id":"W4366160578","doi":"10.1007/s40744-023-00546-0","title":"Phase 2 Dose-Finding Study in Patients with Gout Using SEL-212, a Novel PEGylated Uricase (SEL-037) Combined with Tolerogenic Nanoparticles (SEL-110)","year":2023,"lang":"en","type":"article","venue":"Rheumatology and Therapy","topic":"Gout, Hyperuricemia, Uric Acid","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"Genentech; LG Chem; Sun Pharma; University of British Columbia; Regeneron Pharmaceuticals; Gilead Sciences; Amgen; Pfizer; Eli Lilly and Company","keywords":"Tolerability; Dosing; Uric acid; Pharmacology; Medicine; Gout; Chemistry; Internal medicine; Adverse effect","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001513569,0.00134662,0.001590509,0.0003792036,0.0003655471,0.0008655525,0.0006201105,0.001160444,0.002877828],"category_scores_gemma":[0.0008590709,0.0006144471,0.001070687,0.0002416589,0.0006615159,0.0008242767,0.0003636182,0.002602623,0.0006817842],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005244993,"about_ca_system_score_gemma":0.0009748599,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005067946,"about_ca_topic_score_gemma":0.001257778,"domain_scores_codex":[0.9996835,0.0001420809,0.00001324087,0.00005891616,0.0000366239,0.00006567955],"domain_scores_gemma":[0.9994972,0.00009083805,0.0001029569,0.00004581987,0.00005100001,0.0002122552],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.585618,0.2154806,0.009625547,0.0007905822,0.001627442,0.0005077933,0.0008189517,0.003522701,0.08570207,0.0003894263,0.004154617,0.09176241],"study_design_scores_gemma":[0.2630886,0.7233162,0.007382247,0.00002256357,0.0002089584,0.0002093164,0.0000726557,0.0009798232,0.00274825,0.0001664321,0.00178156,0.00002337449],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9946306,0.0007231071,0.0006637617,0.0002171329,0.00007624488,0.002358545,0.000387645,0.00007427617,0.0008687764],"genre_scores_gemma":[0.9893531,0.0007003773,0.002630688,0.0008431551,0.0001135047,0.003245221,0.0008902614,0.00002698907,0.002196779],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002877828,"threshold_uncertainty_score":0.009627283,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03454139405471354,"score_gpt":0.3017176883983055,"score_spread":0.267176294343592,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}